Literature DB >> 379217

Further evidence for the antibody nature of C3 nephritic factor (C3NeF).

M R Daha, L A van Es.   

Abstract

C3 nephritic factor (C3NeF), found in the sera of some patients with membranoproliferative glomerulonephritis, has been shown to be composed of two heavy and two light chains, like IgG; in addition it shares antigenic determinants with IgG. Purified C3NeF binds to the amplification convertase of complement, C3b,Bb, and thereby prevents decay of its C3-cleaving potential. The capability of C3NeF to bind to C3b,Bb was used as a means for purifying C3NeF to homogeneity. The investigation described in this report suggests that binding of C3NeF to C3b,Bb occurs via the Fab portion of the molecule. Pepsin treatment of eight C3NeF preparations resulted in an average loss of 76% of C3NeF functional activity. Papain treatment induced a loss of approximately 90%. The decrease in functional activity could be attributed to the accelerated rate of dissociation of 125I-F(ab')2 and 125I-Fab fragments from stabilized cell-bound C3b,Bb. The dissociation rate of 125I-F(ab')2 from C3b,Bb was comparable with the decay of the functional activity of C3b,Bb stabilized by F(ab')2 or Fab fragments of C3NeF. Although these results suggest that the stabilizing activity of C3NeF is mediated by the Fab portion of the molecule, it was found that the Fc portion also contributes to its functional activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 379217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis.

Authors:  C G Kallenberg
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 2.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

3.  Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.

Authors:  M R Daha; L A Van Es
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

4.  The role of carbohydrate in the structure and function of nephritic factor.

Authors:  D M Scott; N Amos; S R Bartolotti
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

5.  Anti-Factor B Antibodies and Acute Postinfectious GN in Children.

Authors:  Sophie Chauvet; Romain Berthaud; Magali Devriese; Morgane Mignotet; Paula Vieira Martins; Tania Robe-Rybkine; Maria A Miteva; Aram Gyulkhandanyan; Amélie Ryckewaert; Ferielle Louillet; Elodie Merieau; Guillaume Mestrallet; Caroline Rousset-Rouvière; Eric Thervet; Julien Hogan; Tim Ulinski; Bruno O Villoutreix; Lubka Roumenina; Olivia Boyer; Véronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2020-02-07       Impact factor: 10.121

Review 6.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

Review 7.  Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.

Authors:  M Noris; G Remuzzi
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

8.  Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A Vanes
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Dense deposit disease and the factor H H402 allele.

Authors:  Keith K Lau; Richard J Smith; Peter C Kolbeck; Lavjay Butani
Journal:  Clin Exp Nephrol       Date:  2008-01-26       Impact factor: 2.801

10.  Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.

Authors:  Roberta Donadelli; Patrizia Pulieri; Rossella Piras; Paraskevas Iatropoulos; Elisabetta Valoti; Ariela Benigni; Giuseppe Remuzzi; Marina Noris
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.